Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Data up to Jan 2025
Total Citations Per Year
Abstract
References (20)
Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle
2020 • 3,510 citations
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 • 1,743 citations
Coronaviruses — drug discovery and therapeutic options
2016 • 1,703 citations
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
2004 • 1,684 citations
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
2018 • 1,447 citations
Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection
2017 • 889 citations
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies
2020 • 619 citations
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
2019 • 462 citations
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion
2016 • 267 citations
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
2018 • 257 citations
Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
2016 • 242 citations
The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function
2017 • 223 citations
Influenza virus-related critical illness: prevention, diagnosis, treatment
2019 • 177 citations
Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection
2019 • 144 citations
Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2?
2020 • 119 citations
Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach
2020 • 73 citations
Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease
2019 • 58 citations
Focus on the 2019 Novel Coronavirus (SARS-CoV-2)
2020 • 51 citations
An overview on COVID-19: reality and expectation
2020 • 47 citations
Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016
2018 • 34 citations